Nuclear Entry Mechanism of the Human Polyomavirus JC Virus-like Particle
Qiumin Qu,Hirofumi Sawa,Tadaki Suzuki,Shingo Semba,Chizuka Henmi,Yuki Okada,Masumi Tsuda,Shinya Tanaka,Walter J. Atwood,Kazuo Nagashima
DOI: https://doi.org/10.1074/jbc.m310827200
2004-01-01
Abstract:JC virus (JCV) belongs to the polyomavirus family of double-stranded DNA viruses and causes progressive multifocal leukoencephalopathy in humans. Although transport of virions to the nucleus is an important step in JCV infection, the mechanism of this process has remained unclear. The outer shell of the JCV virion comprises the major capsid protein VP1, which possesses a putative nuclear localization signal (NLS), and virus-like particles (VLPs) consisting of recombinant VP1 exhibit a virion-like structure and physiological functions (cellular attachment and intracytoplasmic trafficking) similar to those of JCV virions. We have now investigated the mechanism of nuclear transport of JCV with the use of VLPs. Wild-type VLPs (wtVLPs) entered the nucleus of most HeLa or SVG cells. The virion structure of VLPs was preserved during transport to the nucleus as revealed by confocal microscopy of cells inoculated with fluorescein isothiocyanate-labeled wtVLPs containing packaged Cy3. The nuclear transport of wtVLPs in digitonin-permeabilized cells was dependent on the addition of importins α and β and was prevented by wheat germ agglutinin or by antibodies to the nuclear pore complex. The nuclear entry of VLPs composed of VP1 with a mutated NLS was greatly inhibited, compared with that of wtVLPs, in both intact and permeabilized cells. Unlike wtVLPs, the mutant VLPs did not bind to importins α or β. Limited proteolysis analysis revealed that the NLS of VP1 was exposed on the surface of wtVLPs. These results suggest that JCV VLPs bind to cellular importins via the NLS of VP1 and are transported into the nucleus through the nuclear pore complex. JC virus (JCV) belongs to the polyomavirus family of double-stranded DNA viruses and causes progressive multifocal leukoencephalopathy in humans. Although transport of virions to the nucleus is an important step in JCV infection, the mechanism of this process has remained unclear. The outer shell of the JCV virion comprises the major capsid protein VP1, which possesses a putative nuclear localization signal (NLS), and virus-like particles (VLPs) consisting of recombinant VP1 exhibit a virion-like structure and physiological functions (cellular attachment and intracytoplasmic trafficking) similar to those of JCV virions. We have now investigated the mechanism of nuclear transport of JCV with the use of VLPs. Wild-type VLPs (wtVLPs) entered the nucleus of most HeLa or SVG cells. The virion structure of VLPs was preserved during transport to the nucleus as revealed by confocal microscopy of cells inoculated with fluorescein isothiocyanate-labeled wtVLPs containing packaged Cy3. The nuclear transport of wtVLPs in digitonin-permeabilized cells was dependent on the addition of importins α and β and was prevented by wheat germ agglutinin or by antibodies to the nuclear pore complex. The nuclear entry of VLPs composed of VP1 with a mutated NLS was greatly inhibited, compared with that of wtVLPs, in both intact and permeabilized cells. Unlike wtVLPs, the mutant VLPs did not bind to importins α or β. Limited proteolysis analysis revealed that the NLS of VP1 was exposed on the surface of wtVLPs. These results suggest that JCV VLPs bind to cellular importins via the NLS of VP1 and are transported into the nucleus through the nuclear pore complex. Progressive multifocal leukoencephalopathy is a fatal demyelinating disease of the central nervous system and is caused by JC virus (JCV) 1The abbreviations used are: JCV, JC virus; SV40, simian virus 40; NPC, nuclear pore complex; NLS, nuclear localization signal; WGA, wheat germ agglutinin; VLP, virus-like particle; wt, wild-type; DMEM, Dulbecco's minimum essential medium; FITC, fluorescein isothiocyanate; PBS, phosphate-buffered saline; GST, glutathione S-transferase; TBS, Tris-buffered saline.1The abbreviations used are: JCV, JC virus; SV40, simian virus 40; NPC, nuclear pore complex; NLS, nuclear localization signal; WGA, wheat germ agglutinin; VLP, virus-like particle; wt, wild-type; DMEM, Dulbecco's minimum essential medium; FITC, fluorescein isothiocyanate; PBS, phosphate-buffered saline; GST, glutathione S-transferase; TBS, Tris-buffered saline. (1Padgett B.L. Walker D.L. ZuRhein G.M. Eckroade R.J. Dessel B.H. Lancet. 1971; 1: 1257-1260Abstract PubMed Scopus (1230) Google Scholar). Although previously rare, this condition is now commonly seen in patients of different age groups as a result of the increasingly widespread use of immunosuppressive chemotherapy and the prevalence of acquired immune deficiency syndrome (2Dworkin M.S. Curr. Clin. Top. Infect. Dis. 2002; 22: 181-195PubMed Google Scholar). JCV belongs to the polyomavirus family, which also includes simian virus 40 (SV40), murine polyomavirus, and BK virus, and is a nonenveloped, icosahedral DNA virus. The circular double-stranded DNA genome comprises 5130 bp and can be functionally divided into three regions: an early coding region, a late coding region, and a noncoding regulatory region (3Frisque R.J. Bream G.L. Cannella M.T. J. Virol. 1984; 51: 458-469Crossref PubMed Google Scholar). The regulatory region, which contains the promoter-enhancer for early and late gene transcription as well as the origin of DNA replication, is located between the early and late coding regions. The early gene encodes the viral regulatory protein, T antigen, whereas the late genes encode the structural capsid proteins VP1, VP2, and VP3 as well as agnoprotein. The early events of JCV infection include attachment of the virion to the host cell surface via a receptor that contains sialic acid (4Komagome R. Sawa H. Suzuki T. Suzuki Y. Tanaka S. Atwood W.J. Nagashima K. J. Virol. 2002; 76: 12992-13000Crossref PubMed Scopus (93) Google Scholar, 5Liu C.K. Wei G. Atwood W.J. J. Virol. 1998; 72: 4643-4649Crossref PubMed Google Scholar). The cytoplasmic transport of JCV in eukaryotic cells is dependent on a complex network of three types of cytoskeletal elements: microtubules, microfilaments, and intermediate filaments (6Ashok A. Atwood W.J. J. Virol. 2003; 77: 1347-1356Crossref PubMed Scopus (72) Google Scholar). After reaching the nucleus, the viral DNA undergoes replication and is transcribed into RNA, which is followed by the production of viral proteins and virion maturation. Successful JCV infection thus depends on the import of the virion into the nucleus, but the mechanism of this import has remained unknown. Entry of macromolecules into the nucleus is an active process and is controlled by the interactions of transport factors (importins) both with their respective macromolecular cargoes and with the nuclear pore complex (NPC) (7Adam S.A. Marr R.S. Gerace L. J. Cell Biol. 1990; 111: 807-816Crossref PubMed Scopus (767) Google Scholar). The nuclear entry of proteins that contain a classical nuclear localization signal (NLS) is mediated by importin α and β heterodimers (8Chi N.C. Adam E.J. Visser G.D. Adam S.A. J. Cell Biol. 1996; 135: 559-569Crossref PubMed Scopus (157) Google Scholar). Importin α recognizes and binds directly to the NLS, whereas importin β, which interacts directly with a protein component of the nuclear pore (nucleoporin), binds the trimeric complex of the NPC and mediates its translocation into the nucleus (9Zhang C. Hutchins J.R. Muhlhausser P. Kutay U. Clarke P.R. Curr. Biol. 2002; 12: 498-502Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar). The major capsid proteins (VP1) of SV40 and murine polyomavirus contain an NLS (10Ishii N. Nakanishi A. Yamada M. Macalalad M.H. Kasamatsu H. J. Virol. 1994; 68: 8209-8216Crossref PubMed Google Scholar, 11Chang D. Haynes II, J.I. Brady J.N. Consigli R.A. Virology. 1992; 191: 978-983Crossref PubMed Scopus (31) Google Scholar). SV40 virions enter the nucleus through the NPC in a manner that is sensitive to wheat germ agglutinin (WGA) or to a monoclonal antibody specific for nucleoporin (12Clever J. Yamada M. Kasamatsu H. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 7333-7337Crossref PubMed Scopus (73) Google Scholar, 13Yamada M. Kasamatsu H. J. Virol. 1993; 67: 119-130Crossref PubMed Google Scholar). However, mutant SV40 virions that are devoid of an NLS have not been generated, leaving unresolved the question of whether such mutant virions would be able to enter the nucleus. The NH2-terminal 12 amino acids of JCV VP1 (MAPTKRKGERKD) include a stretch of basic residues that is similar to the NLS of murine polyomavirus VP1 or SV40 VP1 and is a putative NLS of JCV VP1 (14Chang D. Haynes II, J.I. Brady J.N. Consigli R.A. Virology. 1992; 189: 821-827Crossref PubMed Scopus (44) Google Scholar, 15Ishii N. Minami N. Chen E.Y. Medina A.L. Chico M.M. Kasamatsu H. J. Virol. 1996; 70: 1317-1322Crossref PubMed Google Scholar). This NLS of JCV VP1 was shown to be inefficient in mediating nuclear transport (16Shishido-Hara Y. Hara Y. Larson T. Yasui K. Nagashima K. Stoner G.L. J. Virol. 2000; 74: 1840-1853Crossref PubMed Scopus (41) Google Scholar). However, JCV virus-like particles (VLPs) consisting exclusively of recombinant VP1 purified from either Escherichia coli or a baculovirus-insect cell expression system and assembled by the formation of disulfide bonds (17Chen P.L. Wang M. Ou W.C. Lii C.K. Chen L.S. Chang D. FEBS Lett. 2001; 500: 109-113Crossref PubMed Scopus (54) Google Scholar) were found to be transported to the nucleus of host cells (18Goldmann C. Petry H. Frye S. Ast O. Ebitsch S. Jentsch K.D. Kaup F.J. Weber F. Trebst C. Nisslein T. Hunsmann G. Weber T. Luke W. J. Virol. 1999; 73: 4465-4469Crossref PubMed Google Scholar, 19Suzuki S. Sawa H. Komagome R. Orba Y. Yamada M. Okada Y. Ishida Y. Nishihara H. Tanaka S. Nagashima K. Virology. 2001; 286: 100-112Crossref PubMed Scopus (64) Google Scholar). We have now investigated the mechanism of JCV nuclear entry with VLPs that exhibit both morphological characteristics and physiological functions, including hemagglutination activity, cell attachment, and cellular trafficking, similar to those of JCV virions (18Goldmann C. Petry H. Frye S. Ast O. Ebitsch S. Jentsch K.D. Kaup F.J. Weber F. Trebst C. Nisslein T. Hunsmann G. Weber T. Luke W. J. Virol. 1999; 73: 4465-4469Crossref PubMed Google Scholar, 19Suzuki S. Sawa H. Komagome R. Orba Y. Yamada M. Okada Y. Ishida Y. Nishihara H. Tanaka S. Nagashima K. Virology. 2001; 286: 100-112Crossref PubMed Scopus (64) Google Scholar, 20Chang D. Fung C.Y. Ou W.C. Chao P.C. Li S.Y. Wang M. Huang Y.L. Tzeng T.Y. Tsai R.T. J. Gen. Virol. 1997; 78: 1435-1439Crossref PubMed Scopus (89) Google Scholar). VLPs comprised of wild-type VP1 (wtVLPs), but not those consisting of VP1 with a mutated NLS (ΔNLS-VLPs), were imported into the nucleus of both HeLa and SVG cells. An in vitro transport assay revealed that wtVLPs entered the nucleus in the presence of a cytosolic fraction or of importins α and β, and the nuclear entry of wtVLPs was prevented by WGA or antibodies to the NPC. In addition, limited proteolysis revealed that the NH2-terminal region of VP1 that includes the NLS was exposed on the outer surface of VLPs. These findings suggest that the entry of JCV VLPs into the nucleus of host cells is mediated by interaction of the NLS of VP1 with importins and the NPC. Cell Culture—HeLa human cervical carcinoma cells (JCRB 9004) were obtained from the Health Science Research Resources Bank (Osaka, Japan). SVG human fetal glial cells were as described (5Liu C.K. Wei G. Atwood W.J. J. Virol. 1998; 72: 4643-4649Crossref PubMed Google Scholar). Both cell lines were cultured under 5% CO2 at 37 °C in Dulbecco's minimum essential medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum, 2 mm l-glutamine, penicillin, and streptomycin (Sigma). Plasmid Construction, Cell Transfection, and Immunofluorescence Analysis—The wtVP1 gene of JCV was subcloned from pBR-Mad1 (21Okada Y. Sawa H. Tanaka S. Takada A. Suzuki S. Hasegawa H. Umemura T. Fujisawa J. Tanaka Y. Hall W.W. Nagashima K. J. Biol. Chem. 2000; 275: 17016-17023Abstract Full Text Full Text PDF PubMed Scopus (31) Google Scholar) into the prokaryotic expression vector pET-15b (Novagen, Madison, WI). For construction of ΔNLS-VP1, three amino acids, Lys5, Arg6, and Lys7, of wtVP1 were replaced with Ala, Gly, and Ala, respectively, by site-directed mutagenesis. The DNA fragment encoding ΔNLS-VP1 was also subcloned into pET-15b. To examine localization of recombinant wtVP1 and ΔNLS-VP1 in SVG cells, we subcloned the corresponding DNA fragments into the eukaryotic expression vector pCXN2Flag (22Tokui M. Takei I. Tashiro F. Shimada A. Kasuga A. Ishii M. Ishii T. Takatsu K. Saruta T. Miyazaki J. Biochem. Biophys. Res. Commun. 1997; 233: 527-531Crossref PubMed Scopus (67) Google Scholar), which generates FLAG epitope-tagged recombinant proteins. The inserted DNA fragments of all plasmids were confirmed by sequencing. Twenty-four hours after transfection of SVG cells with the use of Optifect (Invitrogen, Carlsbad, CA), cells were lysed in RIPA buffer (10 mm Tris-HCl (pH 7.5), 150 mm NaCl, 5 mm EDTA, 50 mm NaF, 10% glycerol, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 0.5 mm phenylmethylsulfonyl fluoride), and expression of the recombinant proteins was confirmed by immunoblot analysis with a horseradish peroxidase-conjugated mouse monoclonal antibody to FLAG (M2, Sigma). For immunocytofluorescence analysis, the cells were fixed with 3% paraformaldehyde for 15 min at room temperature and then exposed to 70% methanol for 5 min at -20 °C. The fixed cells were incubated with the M2 antibody to FLAG (1:500 dilution), and immune complexes were detected with Alexa 488-conjugated goat antibodies to mouse immunoglobulin G (Molecular Probes, Eugene, OR). The cells were then examined with a laser-scanning confocal microscope (Olympus, Tokyo, Japan). Preparation of VLPs—VLPs composed of wtVP1 or ΔNLS-VP1 were prepared as previously described (19Suzuki S. Sawa H. Komagome R. Orba Y. Yamada M. Okada Y. Ishida Y. Nishihara H. Tanaka S. Nagashima K. Virology. 2001; 286: 100-112Crossref PubMed Scopus (64) Google Scholar), with slight modifications. The expression plasmids for wtVP1 and ΔNLS-VP1 were separately introduced into competent E. coli BL21(DE3)/pLys cells (Stratagene, La Jolla, CA) by transformation, and expression of the recombinant proteins was induced by incubation of the cells for 4 h at 30 °C with 1 mm isopropyl-β-d-thiogalactopyranoside. The cells were then separated by centrifugation for 10 min at 4,000 × g and resuspended in 20 ml of reassociation buffer (20 mm Tris-HCl (pH 7.5), 150 mm NaCl, 1 mm CaCl2) containing lysozyme (1 mg/ml). After incubation on ice for 30 min and the addition of sodium deoxycholate to a final concentration of 2 mg/ml, the cells were incubated for an additional 10 min on ice and then lysed by five cycles of sonication (15-s bursts), and genomic DNA was digested with DNase I (Amersham Biosciences). The lysate was then centrifuged through a layer of 20% (w/v) sucrose at 100,000 × g for 2 h at 4 °C. The VLPs in the resulting pellet were purified further by CsCl density gradient centrifugation at 100,000 × g for 16 h at 16 °C. All of the gradient fractions were assayed by the hemagglutination test, and those containing the highest activity were pooled (∼0.5 ml) and dialyzed for 24 h at 4 °C against two changes of reassociation buffer (1000 ml). For conjugation with fluorescein isothiocyanate (FITC), VLPs (2 mg) were dissolved in 400 μl of phosphate-buffered saline (PBS), mixed with 40 μl of 1 m carbonate/bicarbonate buffer (pH 9.0) and 156 μl of FITC (Sigma) solution (1 mg/ml in 0.1 m carbonate/bicarbonate buffer (pH 9.0)), and incubated at room temperature for 2 h in the dark. After centrifugation of the mixture at 100,000 × g for 1 h at 4 °C, the pellet was dissolved in PBS and centrifuged overnight at 12,000 × g and 4 °C. The final pellet was resuspended in PBS. The purified VLPs composed of either wtVP1 or ΔNLS-VP1 possessed hemagglutination activity (data not shown) and yielded a prominent band of ∼45 kDa on SDS-PAGE and staining with Coomassie Brilliant Blue (Fig. 1A). The electrophoretic mobility of ΔNLS-VP1 was slightly greater than was that of wtVP1, probably because of the difference in electrical charge between the two proteins. Electron Microscopic Analysis of VLPs—VLPs (5 μl) were transferred to polyvinyl formal-coated grids and left for 5 min. After removal of residual solution with filter paper, 10 drops of 2.5% phosphotungstic acid were placed onto each grid and allowed to air dry. The VLPs were then observed with a model H-800 electron microscope (Hitachi, Tokyo, Japan). Electron microscopy revealed that both wtVLPs and ΔNLS-VLPs exhibited virion particle-like structures with a diameter of 40-50 nm (Fig. 1, B and C). A similar morphology was evident for VLPs after labeling with FITC or packaging of Cy3 (data not shown). Packaging of Cy3 into FITC-labeled VLPs—The fluorescent dye Cy3 (Amersham Biosciences) contains a monofunctional NHS group for conjugation to the amino groups of proteins. To quench this reactive group, we dissolved Cy3 in 50 mm monoethanolamine and incubated the resulting solution on ice overnight. The quenched Cy3 was then packaged into FITC-labeled VLPs by the method described for the packaging of propidium iodide into JCV VLPs (23Goldmann C. Stolte N. Nisslein T. Hunsmann G. Luke W. Petry H. J. Virol. Methods. 2000; 90: 85-90Crossref PubMed Scopus (47) Google Scholar). In brief, purified FITC-labeled VLPs (0.5 mg) were dissociated in 1 ml of dissociation buffer (10 mm Tris-HCl (pH 7.5), 150 mm NaCl, 10 mm EGTA, 5 mm dithiothreitol) by incubation for 1 h at room temperature. Cy3 (100 μg) in 10 μl of 50 mm ethanolamine-HCl (pH 8.0) was added to the dissociated VP1 pentamers, and the resulting mixture was dialyzed overnight at 4 °C in the dark against 1,000 ml of reassociation buffer with a membrane that had an exclusion size of 14 kDa. After the addition of 6 mm MgCl2 and 10 units of DNase I, the FITC-labeled VLPs containing Cy3 were incubated for 1 h at 37 °C, isolated by centrifugation at 100,000 × g for 1 h at 4 °C, and resuspended in 200 μl of PBS. To confirm that Cy3 was indeed packaged into the VLPs, we inoculated cells with a mixture of dissociated VLPs and Cy3 that had not been subjected to subsequent treatment with reassociation buffer. In addition, we subjected the FITC-labeled VLPs containing packaged Cy3 to SDS-PAGE and analyzed the resulting gel by Coomassie Brilliant Blue staining for VP1 and with a fluorescence imager (FLA 3000; Fuji Film, Tokyo, Japan) for Cy3. The fact that VP1 and Cy3 migrated at different positions in the gel confirmed that Cy3 did not bind covalently to VP1 (Fig. 1D). Packaging of DNA into VLPs and Detection of DNA by PCR—To examine whether VLPs with packaged DNA are able to enter the nucleus, we introduced the pBluescript II SK+ plasmid (Stratagene) containing the replication origin of JCV into VLPs by the same method as that used for packaging of Cy3. HeLa or SVG cells were seeded into 60-mm plates, cultured for 24 h, and inoculated for 3 h at 37 °C either with VLPs containing DNA or with JCV in 2 ml of DMEM supplemented with 10% fetal bovine serum. Total DNA was then extracted with the use of a DNA extraction kit (Nucleobond AX; Macherey-Nagel, Easton, PA) either from total lysates of the inoculated cells or from a nuclear fraction thereof prepared as described (7Adam S.A. Marr R.S. Gerace L. J. Cell Biol. 1990; 111: 807-816Crossref PubMed Scopus (767) Google Scholar). The PCR was performed with a Gene Amp PCR system 9700 (Applied Biosystems, Foster City, CA) in a 50-μl reaction mixture containing 1.0 μg of template DNA, 0.2 mm of each deoxynucleoside triphosphate, and 0.1 mm of each primer. For detection of the JCV genome, the amplification protocol included an initial incubation at 95 °C for 5 min; 30 cycles of 95 °C for 45 s, 61 °C for 30 s, and 72 °C for 30 s; and a final extension at 72 °C for 5 min. For detection of the packaged plasmid containing the JCV origin of replication, the protocol comprised an initial incubation at 95 °C for 5 min; 30 cycles of 95 °C for 30 s and 55 °C for 30 s; and a final incubation at 72 °C for 7 min. The primers for detection of the JCV genome (nucleotides 1828 to 2039) were 5′-TGTGCACTCTAATGGGCAAGC-3′ (forward) and 5′-CTAGCTACGCCTTGTGCTCTG-3′ (reverse); those for detection of the packaged plasmid were 5′-GTAAAACGACGGCCAG-3′ (forward) and 5′-CAGGAAACAGCTATGAC-3′ (reverse). The PCR products were separated by electrophoresis on an agarose gel containing ethidium bromide and visualized with ultraviolet illumination. Laser-scanning Confocal Microscopy—HeLa or SVG cells (2 × 104) were transferred to 35-mm glass-bottom dishes (Iwaki, Chiba, Japan) in DMEM supplemented with 10% fetal bovine serum and incubated for 24 h at 37 °C. The cells were then inoculated for 1 h at 4 °C in DMEM with FITC-labeled VLPs with or without packaged Cy3 (0.256 to 2.56 units of hemagglutination activity per cell). After three washes with PBS, the cells were incubated at 37 °C in DMEM and examined at various times with a laser-scanning confocal microscope (Olympus). For determination of the frequency of import of VLPs into the nucleus, the cells were fixed 3 h after inoculation by incubation for 10 min at room temperature with 3% paraformaldehyde and were then stained for 5 min with propidium iodide (0.2 μg/ml). The number of cells in which FITC-labeled VLPs were detected in the nucleus (as revealed by propidium iodide staining) was counted with the laser-scanning confocal microscope and expressed as a percentage of total cells. In Vitro Nuclear Transport Assay—HeLa or SVG cells were transferred to 8-well coverslips for 24 h, washed twice with a solution containing 20 mm Hepes-NaOH (pH 7.3), 110 mm potassium acetate, 5 mm sodium acetate, 2 mm magnesium acetate, and 1 mm EGTA, and then permeabilized for 5 min on ice with digitonin (90 μg/ml) in the wash solution supplemented with 2 mm dithiothreitol, 1 mm phenylmethylsulfonyl fluoride, as well as leupeptin, pepstatin, and aprotinin each at 1 μg/ml (transport buffer). This concentration of digitonin was selected as optimal from several different concentrations (40, 60, 90, and 120 μg/ml) tested. The cells were then washed three times with transport buffer and incubated first for 5 min on ice with the same solution to deplete cytosolic factors and then for 15 min at room temperature with 10 μl of transport buffer in the absence or presence of either WGA (50 μg/ml) or a mouse monoclonal antibody (200 μg/ml) to the NPC (Co-vance, Richmond, CA). They were washed twice with transport buffer before the addition of 10 μl of transport buffer as well as 1 μl of an ATP-regenerating system (1 mm ATP, 5 mm creatine phosphate, 20 units of creatine phosphokinase) and 10 μl of either a cytosolic fraction (68 μg of protein) or recombinant importins α or β (0.3 μg of each). After inoculation with 5 μl of FITC-labeled VLPs, the cells were incubated for 30 min at 37 °C, washed extensively with transport buffer, fixed for 10 min with 3% paraformaldehyde, and examined by laser-scanning confocal microscopy. A cytosolic fraction was prepared as previously described (7Adam S.A. Marr R.S. Gerace L. J. Cell Biol. 1990; 111: 807-816Crossref PubMed Scopus (767) Google Scholar). In brief, HeLa or SVG cells in the exponential phase of growth were harvested by centrifugation for 10 min at 900 × g and washed twice with ice-cold PBS. They were then washed with a solution containing 10 mm Hepes-NaOH (pH 7.3), 10 mm potassium acetate, 2 mm magnesium acetate, and 2 mm dithiothreitol, resuspended in 5 volumes of lysis buffer (5 mm Hepes-NaOH (pH 7.4), 10 mm potassium acetate, 2 mm magnesium acetate, 2 mm dithiothreitol, 20 μm cytochalasin B, 1 mm phenylmethylsulfonyl fluoride, and aprotinin, leupeptin, and pepstatin each at 1 μg/ml), incubated for 10 min on ice, and homogenized in a steel homogenizer (10 strokes). The homogenate was centrifuged at 100,000 × g for 40 min at 4 °C, and the resulting supernatant was dialyzed against transport buffer and then concentrated with a membrane that eliminates proteins of <10 kDa (Millipore). Recombinant importins α and β were produced in and purified from E. coli as glutathione S-transferase (GST) fusion proteins as described previously (24Imamoto N. Shimamoto T. Kose S. Takao T. Tachibana T. Matsubae M. Sekimoto T. Shimonishi Y. Yoneda Y. FEBS Lett. 1995; 368: 415-419Crossref PubMed Scopus (155) Google Scholar, 25Imamoto N. Shimamoto T. Takao T. Tachibana T. Kose S. Matsubae M. Sekimoto T. Shimonishi Y. Yoneda Y. EMBO J. 1995; 14: 3617-3626Crossref PubMed Scopus (270) Google Scholar). VLP Overlay Assay—A VLP overlay assay was performed as previously described (4Komagome R. Sawa H. Suzuki T. Suzuki Y. Tanaka S. Atwood W.J. Nagashima K. J. Virol. 2002; 76: 12992-13000Crossref PubMed Scopus (93) Google Scholar). Recombinant GST-importin α, GST-importin β, both importins, or GST alone were separated by SDS-PAGE on an 8% gel and then transferred to a polyvinylidene difluoride membrane. Nonspecific binding sites on the membrane were blocked by incubation for 1 h with 5% skim milk in Tris-buffered saline (TBS: 20 mm Tris-HCl (pH 7.5), 150 mm NaCl) containing 0.1% Tween 20 (TBS-T). The membrane was then incubated for 2 h at 4 °C with purified VLPs (5 μg/ml) suspended in blocking solution. After four washes with TBS-T, the membrane was incubated for 1 h at 4 °C with rabbit polyclonal antibodies (1:1000 dilution in TBS-T) to VP1 (26Okada Y. Sawa H. Endo S. Orba Y. Umemura T. Nishihara H. Stan A.C. Tanaka S. Takahashi H. Nagashima K. Acta Neuropathol. (Berl.). 2002; 104: 130-136Crossref PubMed Scopus (46) Google Scholar, 27Okada Y. Endo S. Takahashi H. Sawa H. Umemura T. Nagashima K. J. Neurovirol. 2001; 7: 302-306Crossref PubMed Scopus (57) Google Scholar) or GST (Amersham Biosciences). The membrane was again washed with TBS-T and then incubated for 1 h at 4 °C with horseradish peroxidase-conjugated goat F(ab′)2 (1:3000 dilution) to rabbit immunoglobulin (BioSource Int., Camarillo, CA). Immune complexes were detected with ECL reagents (Amersham Biosciences) and a LAS-1000 Plus image analyzer (Fuji Film). Limited Proteolysis of VLPs and VP1—VLPs and VP1 were further purified by gel filtration on a column of HiLoad 16/60 Superdex 200 (Amersham Biosciences). VLPs were applied to the column after its equilibration with TBS and eluted in the void volume with the same solution at a flow rate of 0.5 ml/min. For purification of VP1, VLPs were dialyzed against dissociation buffer overnight at 4 °C and then applied to the same column after its equilibration with dissociation buffer. VP1 monomers eluted in fractions corresponding to a molecular size of ∼70 kDa. The purified VLPs and VP1 monomers were dialyzed against TBS and dissociation buffer, respectively. For limited proteolysis, VLPs or VP1 monomers (1 mg/ml) were digested at room temperature with trypsin (10 μg/ml) (sequencing grade; Roche Diagnostics) in TBS or dissociation buffer, respectively. The reaction was terminated after various times by the addition of phenylmethylsulfonyl fluoride at a final concentration of 2 mm. The digestion products were fractionated by SDS-PAGE on a 15% gel, transferred to an Immobilon-P membrane (Millipore), and stained with Coomassie Brilliant Blue, and selected bands were excised, destained with methanol, and subjected to amino acid sequence analysis with a Procise49X cLC Protein Sequencer (Applied Biosystems). Entry of VLPs into the Nucleus—The function of the amino acid stretch at the NH2 terminus of JCV VP1 was examined by transfecting SVG cells with expression vectors for either FLAG-wtVP1 or FLAG-ΔNLS-VP1. The electrophoretic mobility of FLAG-ΔNLS-VP1 was little greater than that of FLAG-wtVP1, which was similar to the band previously shown in Fig. 1A, and the expression level of FLAG-wtVP1 was slightly higher than that of FLAG-ΔNLS-VP1 (Fig. 2A). FLAG-wtVP1 was localized predominantly in the nucleus of SVG cells, however, FLAG-ΔNLS-VP1 was mostly restricted to the cytoplasm (Fig. 2B), suggesting that the basic amino acid region at the NH2 terminus of VP1 functions as an NLS. Nuclear entry of JCV VLPs was assayed by inoculating HeLa or SVG cells, which are nonpermissive and permissive, respectively, for JCV infection, with FITC-labeled VLPs. The FITC signal of wtVLPs was detected in the nucleus of HeLa cells after subsequent incubation of the cells for 1 h at 37 °C (Fig. 3A). Nuclear fluorescence increased in intensity during incubation for an additional 2 h, with 95.6% of HeLa cells containing wtVLPs in the nucleus 3 h post-inoculation. In contrast, the nuclear entry of ΔNLS-VLPs was markedly inhibited in HeLa cells, even though these particles were able to enter the cytoplasm (Fig. 3A). Only 2.2% of HeLa cells contained ΔNLS-VLPs in the nucleus 3 h post-inoculation. Similar results were obtained with SVG cells (Fig. 3B). Whereas 95.4% of SVG cells manifested wtVLPs in the nucleus 3 h post-inoculation, the corresponding value for ΔNLS-VLPs was only 6.1%. These results indicated that the NLS of VP1 is important for the nuclear translocation of VLPs in host cells. To exclude the possibility that our detection of the FITC signal of wtVLPs in the nucleus of inoculated host cells actually represented the nuclear translocation of FITC-labeled VP1 monomers contaminating the VLP preparation, we inoculated cells with FITC-labeled wtVLPs containing packaged Cy3. The FITC (green) and Cy3 (red) signals exhibited similar temporal and spatial patterns of accumulation in the nucleus of either HeLa (Fig. 4A) or SVG (Fig. 4B) cells, indicating that FITC and Cy3 entered the nucleus as surface and internal components, respectively, of intact wtVLPs. Consistent with the results obtained with FITC-labeled ΔNLS-VLPs (Fig. 3), the FITC and Cy3 signals derived from FITC-labeled ΔNLS-VLPs containing packag